Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Controlled Level EVERolimus in Acute Coronary Syndromes (CLEVER-ACS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2015 by University of Zurich
Sponsor:
Collaborators:
Swiss National Science Foundation
Novartis
Information provided by (Responsible Party):
University of Zurich
ClinicalTrials.gov Identifier:
NCT01529554
First received: February 3, 2012
Last updated: August 19, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)